ARDS

Showing    of 2 results

Athersys and UH announce activation of first clinical site for MACOVIA study, a pivotal Phase 2/3 study evaluating Multistem® cell therapy for COVID-19 induced ARDS

UH Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients - News Release

Clinical Trial Seeks Potential ARDS Treatment

MultiStem® Therapy in Acute Respiratory Distress Syndrome shows promising early results - Innovations in Pulmonology and Sleep Medicine | Summer 2019

Results are loading...
Back to Top